Literature DB >> 35094186

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers.

Angelin Tresa Mathew1, Bhav Jain2, Edward Christopher Dee3,4, Jordan Johnson5, Fumiko Chino6.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35094186      PMCID： PMC9479750          DOI： 10.1245/s10434-022-11349-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  5 in total

1.  Financial Toxicity of Cancer Care: It's Time to Intervene.

Authors:  S Yousuf Zafar
Journal:  J Natl Cancer Inst       Date:  2015-12-11       Impact factor: 13.506

2.  Surprise Billing-A Flashpoint for Major Policy Issues in Health Care.

Authors:  Carrie Colla
Journal:  JAMA       Date:  2021-02-23       Impact factor: 56.272

3.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

4.  Association Between Availability of a Price Transparency Tool and Outpatient Spending.

Authors:  Sunita Desai; Laura A Hatfield; Andrew L Hicks; Michael E Chernew; Ateev Mehrotra
Journal:  JAMA       Date:  2016-05-03       Impact factor: 56.272

5.  Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021.

Authors:  Roy Xiao; Vinay K Rathi; Cary P Gross; Joseph S Ross; Rosh K V Sethi
Journal:  JAMA       Date:  2021-06-04       Impact factor: 56.272
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.